Bladder cancer (BC) is the most common tumor of the urinary tract. Increasing evidence showed that long non-coding RNA (lncRNA) is a critical regulator in cancer development and progression. However, the functions of lncRNAs in the development of BC remain mostly undefined.
Access represents a deciding factor in patient health care outcomes, particularly in subspecialty surgical care. Urology is no exception.
Urinary incontinence is a widespread disorder affecting millions of people over the world with impressive and probably still underestimated rebounds on personal and social wellbeing.
Robert Flavell: So it’s my pleasure today to welcome you all to join us today for this Prostate Cancer Outreach Webinar. This webinar has been organized in collaboration with the Society of Nuclear Medicine and Molecular Imaging Prostate Cancer Outreach Working Group, together with faculty from the University of California in San Francisco. And the […]
Robert Flavell: So it’s my pleasure today to welcome you all to join us today for this Prostate Cancer Outreach Webinar. This webinar has been organized in collaboration with the Society of Nuclear Medicine and Molecular Imaging Prostate Cancer Outreach Working Group, together with faculty from the University of California in San Francisco. And the […]
Robert Flavell: It’s my pleasure today to welcome you all to join us today for this Prostate Cancer Outreach Webinar. This webinar has been organized in collaboration with the Society of Nuclear Medicine and Molecular Imaging’s Prostate Cancer Outreach Working Group together with faculty from the University of California in San Francisco. And the topic […]
Robert Flavell: So it’s my pleasure today to welcome you all to join us today for this Prostate Cancer Outreach Webinar. This webinar has been organized in collaboration with the Society of Nuclear Medicine and Molecular Imaging’s Prostate Cancer Outreach Working Group together with faculty from the University of California in San Francisco. And the […]
Robert Flavell: It’s my pleasure today to welcome you all to join us today for this Prostate Cancer Outreach Webinar. This webinar has been organized in collaboration with the Society of Nuclear Medicine and Molecular Imaging’s Prostate Cancer Outreach Working Group, together with faculty from the University of California in San Francisco. And the topic […]
Alicia Morgans, MD: Hi, my name is Alicia Morgans and I’m a GU medical oncologist and Associate Professor of Medicine at Northwestern University. I am so excited to have here with me today, a friend and colleague, Dr. Felix Feng, who is a professor of radiation oncology, urology, and medicine, as well as being the […]
Alicia Morgans: Hi, this is Alicia Morgans, GU Medical Oncologist, and Associate Professor of Medicine at Northwestern University. I am so excited to have a conversation with Dr. Felix Feng, who is a Professor of Radiation, Oncology, Urology, and Medicine at UCSF, who is talking to us about the use of ADT in intermediate-risk prostate […]
